VANCOUVER, BC / February 27, 2014 / ACCESSWIRE / Abattis Bioceuticals Corp. ("Abattis" or the "Company") (CSE:ATT) (OTC:ATTBF - News), is pleased to announce that it has signed a letter of intent with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback